Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally

Nanoparticles (NPs) are increasingly being used for drug delivery, as well as antigen carriers and immunostimulants for the purpose of developing vaccines. In this work, we examined how intranasal (i.n.) priming followed by i.n. or subcutaneous (s.c.) boosting immunization affects the humoral immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Howe, Savannah E., Sowa, Gavin, Konjufca, Vjollca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698832/
https://www.ncbi.nlm.nih.gov/pubmed/31558001
http://dx.doi.org/10.3390/antib5040020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698832/
https://www.ncbi.nlm.nih.gov/pubmed/31558001
http://dx.doi.org/10.3390/antib5040020

Ejemplares similares